Wound Management Sells Non-Core Subsidiary; Intends to Focus on CellerateRX and Medical Device Business

Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK), an emerging innovator in advanced wound care solutions, has sold its wholly-owned subsidiary, Secure eHealth, LLC (“Secure eHealth”), to two entities that previously financed the acquisition of Secure eHealth by WNDM in January 2010. In...

TONIX Pharmaceuticals Completes $4.3 Private Placement Funding

TONIX Pharmaceuticals, a New York-based specialty pharmaceutical company (TNXP.OB),  focused on developing therapies to treat central nervous system conditions such as fibromyalgia (FM) and post-traumatic stress disorder (PTSD), just completed a $4.3 private placement offering to institutional and...

This Week In Diagnostics

IPSOGEN acquires rights for new cancer biomarkers IPSOGEN SA (Alternext: ALIPS), a majority-owned subsidiary of QIAGEN N.V. (Nasdaq: QGEN), has reported that it has acquired the worldwide exclusive rights to testing for mutations of the IDH1 and IDH2 genes for diagnostic purposes from Baltimore,...